0
CrossRoads Pharmaceutical Sector report March 2022
£0.00
In stock
Product Details
The March edition of the Pharmaceutical CrossRoads TM report focuses on Russia/Ukraine, covering both commercial exposure and the implications for clinical trials. Topics:
The industry’s exposure to Russia and Eastern Europe
Commercial risks in Russia and globally
Potential action on the part of Russian authorities and Pharmaceutical companies
Relevance of the region for clinical trials
Scope for the disruption of clinical trials
Scope to mitigate trial disruption
Save this product for later
CrossRoads Pharmaceutical Sector report March 2022
Display prices in:
GBP